Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Lordick

Showing results (81-90 of 114) with videos related to

Pageof 12
Sort By:
ESMO Gastrointestinal Oncology|February 6, 2026
Role of the microbiome in the development and treatment of gastric cancer: an overview of the biological and clinical landscapeC A Cella, D Ciardiello, L Gervaso, et al.
Der Pathologe|July 5, 2016
[HER2 testing in gastric cancer : Results of a meeting of German experts]G Baretton, M Dietel, T Gaiser, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 4, 2020
Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensusG Curigliano, S Banerjee, A Cervantes, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 25, 2009
Cetuximab plus cisplatin-5-fluorouracil versus cisplatin-5-fluorouracil alone in first-line metastatic squamous cell carcinoma of the esophagus: a randomized phase II study of the Arbeitsgemeinschaft Internistische OnkologieS Lorenzen, T Schuster, R Porschen, et al.
Zeitschrift Fur Gastroenterologie|August 17, 2016
[HER2 testing in gastric cancer - results of a German expert meeting]F Lordick, S E Al-Batran, R D Hofheinz, et al.
European Journal of Cancer Care|January 31, 2017
Factors associated with non-participation and dropout among cancer patients in a cluster-randomised controlled trialJ Roick, H Danker, A Kersting, et al.
ESMO Open|August 1, 2024
Estimating the prevalence of mental disorders in patients with newly diagnosed cancer in relation to socioeconomic status: a multicenter prospective observational studyU Goerling, J Ernst, P Esser, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 27, 2007
Capecitabine plus oxaliplatin (CapOx) versus capecitabine plus gemcitabine (CapGem) versus gemcitabine plus oxaliplatin (mGemOx): final results of a multicenter randomized phase II trial in advanced pancreatic cancerS Boeck, T Hoehler, G Seipelt, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 4, 2016
The multidisciplinary management of gastro-oesophageal junction tumours: European Society of Digestive Oncology (ESDO): Expert discussion and report from the 16th ESMO World Congress on Gastrointestinal Cancer, BarcelonaJ-L Van Laethem, F Carneiro, M Ducreux, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 4, 2014
Survival of patients with initially unresectable colorectal liver metastases treated with FOLFOX/cetuximab or FOLFIRI/cetuximab in a multidisciplinary concept (CELIM study)G Folprecht, T Gruenberger, W Bechstein, et al.
Pageof 12

Showing results (81-90 of 114) with videos related to

Sort By:
Pageof 12
ESMO Gastrointestinal Oncology|February 6, 2026
Role of the microbiome in the development and treatment of gastric cancer: an overview of the biological and clinical landscapeC A Cella, D Ciardiello, L Gervaso, et al.
Der Pathologe|July 5, 2016
[HER2 testing in gastric cancer : Results of a meeting of German experts]G Baretton, M Dietel, T Gaiser, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 4, 2020
Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensusG Curigliano, S Banerjee, A Cervantes, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 25, 2009
Cetuximab plus cisplatin-5-fluorouracil versus cisplatin-5-fluorouracil alone in first-line metastatic squamous cell carcinoma of the esophagus: a randomized phase II study of the Arbeitsgemeinschaft Internistische OnkologieS Lorenzen, T Schuster, R Porschen, et al.
Zeitschrift Fur Gastroenterologie|August 17, 2016
[HER2 testing in gastric cancer - results of a German expert meeting]F Lordick, S E Al-Batran, R D Hofheinz, et al.
European Journal of Cancer Care|January 31, 2017
Factors associated with non-participation and dropout among cancer patients in a cluster-randomised controlled trialJ Roick, H Danker, A Kersting, et al.
ESMO Open|August 1, 2024
Estimating the prevalence of mental disorders in patients with newly diagnosed cancer in relation to socioeconomic status: a multicenter prospective observational studyU Goerling, J Ernst, P Esser, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 27, 2007
Capecitabine plus oxaliplatin (CapOx) versus capecitabine plus gemcitabine (CapGem) versus gemcitabine plus oxaliplatin (mGemOx): final results of a multicenter randomized phase II trial in advanced pancreatic cancerS Boeck, T Hoehler, G Seipelt, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 4, 2016
The multidisciplinary management of gastro-oesophageal junction tumours: European Society of Digestive Oncology (ESDO): Expert discussion and report from the 16th ESMO World Congress on Gastrointestinal Cancer, BarcelonaJ-L Van Laethem, F Carneiro, M Ducreux, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 4, 2014
Survival of patients with initially unresectable colorectal liver metastases treated with FOLFOX/cetuximab or FOLFIRI/cetuximab in a multidisciplinary concept (CELIM study)G Folprecht, T Gruenberger, W Bechstein, et al.
Pageof 12